文献速递血栓与止血

骨保护素在血管性血友病因子从内皮细胞释放过程中调节血小板黏附

Osteoprotegerin modulates platelet adhesion to von Willebrand factor during release from endothelial cells.
PubMed 文献 · J Thromb Haemost · 2021-12-03

本研究探讨内皮细胞受刺激分泌的多聚体血管性血友病因子(VWF)束与血小板结合的效率,以及位于怀布尔-帕拉德体、与VWF血小板结合域相互作用的骨保护素的作用。研究发现VWF从内皮细胞释放后开放血小板结合位点,但并非所有位点被占据,骨保护素可降低血小板对VWF的黏附,提示存在调控机制。

要点

  • 内皮细胞受刺激分泌的VWF丝仅部分被血小板覆盖,提示存在调控。
  • 骨保护素在灌注试验中使血小板对VWF的黏附降低40%±18%。
  • siRNA下调内皮骨保护素表达使血小板对VWF丝的黏附增加1.8倍。

核心结论

  • VWF从内皮细胞释放后开放血小板结合位点,与是否存在血流无关,但并非所有可用血小板结合位点均被占据,提示存在一定程度的调控,部分调控涉及与VWF共分泌的内皮蛋白如骨保护素,该调控机制在炎症条件下可能更具相关性。

研究设计与样本

  • 使用特异性结合VWF活性血小板结合构象的纳米抗体VWF/AU-a11研究VWF构象,并结合灌注试验、siRNA下调内皮骨保护素表达、病毒感染的血浆检测、去氨加压素治疗的甲型血友病患者血浆检测及小鼠模型进行实验研究。

主要发现

  • 内皮细胞受刺激分泌后,VWF丝仅部分被血小板覆盖,而VWD 2B型突变或利托菌素使血小板结合增强2–3倍。
  • 骨保护素在灌注试验中使血小板对VWF的黏附降低40%±18%。
  • siRNA介导的内皮骨保护素表达下调使血小板对VWF丝的黏附增加1.8倍。
  • 病毒感染时,血浆VWF和骨保护素水平一致性升高;而去氨加压素治疗的甲型血友病患者血浆中未观察到这种升高。
  • 小鼠模型中,载体处理小鼠肝内皮细胞骨保护素表达低,刀豆蛋白A处理使VWF和骨保护素表达分别增加4倍和40倍,血浆骨保护素/VWF比值增加30倍。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Platelet-binding Von Willebrand Factor (VWF) strings assemble upon stimulated secretion from endothelial cells. OBJECTIVES: To investigate the efficiency of platelet binding to multi-molecular VWF bundles secreted from endothelial cells and to investigate the role of osteoprotegerin, a protein located in Weibel-Palade bodies that interacts with the VWF platelet binding domain. METHODS: The nanobody VWF/AU-a11 that specifically binds to VWF in its active platelet-binding conformation was used to investigate the conformation of VWF. RESULTS: Upon stimulated secretion from endothelial cells, VWF strings were only partially covered with platelets, while a VWD-type 2B mutation or ristocetin enhanced platelet binding by 2-3-fold. Osteoprotegrin, reduces platelet adhesion to VWF by 40% ± 18% in perfusion assays. siRNA-mediated down-regulation of endothelial osteoprotegerin expression resulted in a 1.8-fold increase in platelet adhesion to VWF strings. Upon viral infection, there is a concordant rise in VWF and osteoprotegerin plasma levels. Unexpectedly, no such increase was observed in plasma of desmopressin-treated hemophilia A-patients. In a mouse model, osteoprotegerin expression was low in liver endothelial cells of vehicle-treated mice, and concanavalin A-treatment increased VWF and osteoprotegerin expression 4- and 40-fold, respectively. This increase was translated in a 30-fold increased osteoprotegerin/VWF ratio in plasma. CONCLUSIONS: Release of VWF from endothelial cells opens the platelet-binding site, irrespective of the presence of flow. However, not all available platelet-binding sites are being occupied, suggesting some extent of regulation. Part of this regulation involves endothelial proteins that are co-secreted with VWF, like osteoprotegerin. This regulatory mechanism may be of more relevance under inflammatory conditions.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Wohner N, Sebastian S, Muczynski V, et al. Osteoprotegerin modulates platelet adhesion to von Willebrand factor during release from endothelial cells. J Thromb Haemost. 2021. PMID: 34816579. doi:10.1111/jth.15598

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。